MONTREAL, Nov. 29, 2007 (PRIME NEWSWIRE) -- Viropro Inc. (OTC BB:VPRO.OB - News) is pleased to announce that its subsidiary Viropro International Inc. (``Viropro’’) has received payment for the first Milestone of the contract signed with Intas Biopharmaceuticals Limited related to the development and production of an undisclosed therapeutic protein.
